Remove Article Remove Immunization Remove Labelling
article thumbnail

Pharmacists Can Improve Insulin Management Through Counseling

Drug Topics

Simple techniques, such as color-coding or clearly labeling insulin pens and vials with a marker can help patients remember which insulin to use and when. Mealtime insulin must be taken close to eating, ranging from 30 minutes before to just after the meal, depending on the product.

article thumbnail

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

Private-Label Partnerships can Streamline Operations and Enhance the Customer Experience Offering a broad selection of private-label OTC products can help your pharmacy stay competitive and support your customers’ evolving needs. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release. Accessed June 12, 2025.

article thumbnail

Independent Pharmacy Innovation Spotlighted at McKesson ideaShare 2025

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

article thumbnail

Neoadjuvant Nivolumab With Chemotherapy Yields Significant Overall Survival Benefit in Resectable NSCLC

Pharmacy Times

These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology.

article thumbnail

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

Although no formal contraindications are listed in AstraZeneca’s US labeling, perioperative management may require holding acalabrutinib 3 to 7 days before and after surgery to minimize bleeding risk. Hepatotoxicity and drug-induced liver injury are additional risks that require monitoring. Cancer Therapy Advisor. June 21, 2024.

FDA
article thumbnail

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Pharmacy Times

The findings emphasize nemolizumab’s swift response in treating atopic dermatitis symptoms, along with its long-term effectiveness in prurigo nodularis, as demonstrated in the OLYMPIA open-label extension trial (NCT04204616).